Literature DB >> 35259851

Toxicities of amyloid-beta and tau protein are reciprocally enhanced in the Drosophila model.

Zhen-Dong Sun1, Jia-Xin Hu1, Jia-Rui Wu1, Bing Zhou2, Yun-Peng Huang1.   

Abstract

Extracellular aggregation of amyloid-beta (Aβ) and intracellular tau tangles are two major pathogenic hallmarks and critical factors of Alzheimer's disease. A linear interaction between Aβ and tau protein has been characterized in several models. Aβ induces tau hyperphosphorylation through a complex mechanism; however, the master regulators involved in this linear process are still unclear. In our study with Drosophila melanogaster, we found that Aβ regulated tau hyperphosphorylation and toxicity by activating c-Jun N-terminal kinase. Importantly, Aβ toxicity was dependent on tau hyperphosphorylation, and flies with hypophosphorylated tau were insulated against Aβ-induced toxicity. Strikingly, tau accumulation reciprocally interfered with Aβ degradation and correlated with the reduction in mRNA expression of genes encoding Aβ-degrading enzymes, including dNep1, dNep3, dMmp2, dNep4, and dIDE. Our results indicate that Aβ and tau protein work synergistically to further accelerate Alzheimer's disease progression and may be considered as a combined target for future development of Alzheimer's disease therapeutics.

Entities:  

Keywords:  Alzheimer’s disease; Drosophila melanogaster; amyloid-beta; amyloid-beta degradation; c-Jun N-terminal kinase (JNK); neurodegeneration; tau; tau hyperphosphorylation

Year:  2022        PMID: 35259851      PMCID: PMC9083152          DOI: 10.4103/1673-5374.336872

Source DB:  PubMed          Journal:  Neural Regen Res        ISSN: 1673-5374            Impact factor:   6.058


  73 in total

1.  Amyloid-β plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation.

Authors:  Zhuohao He; Jing L Guo; Jennifer D McBride; Sneha Narasimhan; Hyesung Kim; Lakshmi Changolkar; Bin Zhang; Ronald J Gathagan; Cuiyong Yue; Christopher Dengler; Anna Stieber; Magdalena Nitla; Douglas A Coulter; Ted Abel; Kurt R Brunden; John Q Trojanowski; Virginia M-Y Lee
Journal:  Nat Med       Date:  2017-12-04       Impact factor: 53.440

2.  Inhibition of human high-affinity copper importer Ctr1 orthologous in the nervous system of Drosophila ameliorates Aβ42-induced Alzheimer's disease-like symptoms.

Authors:  Minglin Lang; Qiangwang Fan; Lei Wang; Yajun Zheng; Guiran Xiao; Xiaoxi Wang; Wei Wang; Yi Zhong; Bing Zhou
Journal:  Neurobiol Aging       Date:  2013-07-02       Impact factor: 4.673

3.  Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.

Authors:  Rik Ossenkoppele; Daniel R Schonhaut; Michael Schöll; Samuel N Lockhart; Nagehan Ayakta; Suzanne L Baker; James P O'Neil; Mustafa Janabi; Andreas Lazaris; Averill Cantwell; Jacob Vogel; Miguel Santos; Zachary A Miller; Brianne M Bettcher; Keith A Vossel; Joel H Kramer; Maria L Gorno-Tempini; Bruce L Miller; William J Jagust; Gil D Rabinovici
Journal:  Brain       Date:  2016-03-08       Impact factor: 13.501

4.  Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines.

Authors:  Hans Zempel; Edda Thies; Eckhard Mandelkow; Eva-Maria Mandelkow
Journal:  J Neurosci       Date:  2010-09-08       Impact factor: 6.167

Review 5.  Tau-mediated neurodegeneration in Alzheimer's disease and related disorders.

Authors:  Carlo Ballatore; Virginia M-Y Lee; John Q Trojanowski
Journal:  Nat Rev Neurosci       Date:  2007-09       Impact factor: 34.870

Review 6.  Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies.

Authors:  Yu Yamazaki; Na Zhao; Thomas R Caulfield; Chia-Chen Liu; Guojun Bu
Journal:  Nat Rev Neurol       Date:  2019-07-31       Impact factor: 44.711

7.  Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.

Authors:  Rosemary J Jackson; Nikita Rudinskiy; Abigail G Herrmann; Shaun Croft; JeeSoo Monica Kim; Veselina Petrova; Juan Jose Ramos-Rodriguez; Rose Pitstick; Susanne Wegmann; Monica Garcia-Alloza; George A Carlson; Bradley T Hyman; Tara L Spires-Jones
Journal:  Eur J Neurosci       Date:  2016-11-12       Impact factor: 3.386

8.  FlyPrimerBank: an online database for Drosophila melanogaster gene expression analysis and knockdown evaluation of RNAi reagents.

Authors:  Yanhui Hu; Richelle Sopko; Marianna Foos; Colleen Kelley; Ian Flockhart; Noemie Ammeux; Xiaowei Wang; Lizabeth Perkins; Norbert Perrimon; Stephanie E Mohr
Journal:  G3 (Bethesda)       Date:  2013-09-04       Impact factor: 3.154

Review 9.  Drosophila melanogaster as a model organism for Alzheimer's disease.

Authors:  Katja Prüßing; Aaron Voigt; Jörg B Schulz
Journal:  Mol Neurodegener       Date:  2013-11-22       Impact factor: 14.195

10.  Seed-induced acceleration of amyloid-β mediated neurotoxicity in vivo.

Authors:  Ramona F Sowade; Thomas R Jahn
Journal:  Nat Commun       Date:  2017-09-11       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.